Search results for "obstetrics and gynecology"

showing 10 items of 1542 documents

P29, an oestrogen receptor-associated protein, is down- regulated by mifepristone in first trimester human placenta and decidua

1991

P29 is an oestrogen receptor-associated protein which acts as a marker of oestrogen action in several systems. The concentration of P29 was measured in placenta and decidua from women following medical termination of pregnancy with the antiprogesterone steroid mifepristone (RU 38,486) and a prostaglandin E1 analogue, and compared with the concentration of P29 found in matched controls undergoing surgical aspiration of pregnancy. Oestrogen receptors were also measured in the same samples. Placental and decidual P29 concentrations (IU/mg protein) in patients treated with mifepristone were 9.6 (4.6-54) and 4.8 (1.3-13.3) (median and range), respectively. These values were significantly lower t…

Adultmedicine.medical_specialtyAdolescentmedicine.drug_classPlacentaUterusDown-RegulationEstrogen receptorPregnancyInternal medicinePlacentaDeciduamedicineHumansReceptorHeat-Shock ProteinsAbortifacientbusiness.industryRehabilitationDeciduaObstetrics and GynecologyMifepristonePhosphoproteinsMifepristonePregnancy Trimester FirstEndocrinologymedicine.anatomical_structureReceptors EstrogenReproductive MedicineEstrogenAbortion Legalembryonic structuresFemalebusinessmedicine.drugHuman Reproduction
researchProduct

Laparoscopic staging of apparent early stage ovarian cancer: Results of a large, retrospective, multi-institutional series

2014

Abstract Objective The aim of this study is to analyze the safety, adequacy, perioperative and survival figures in a large series of laparoscopic staging of patients with apparent early stage ovarian malignancies (ESOM). Patients and methods Retrospective data from seven gynecologic oncology service databases were searched for ESOM patients undergoing immediate laparoscopic staging or delayed laparoscopic staging after an incidental diagnosis of ESOM. Between May 2000 and February 2014, 300 patients were selected: 150 had been submitted to immediate laparoscopic staging (Group 1), while 150 had undergone delayed laparoscopic staging (Group 2) of ESOM. All surgical, pathologic, and oncologic…

Adultmedicine.medical_specialtyAdolescentmedicine.medical_treatmentGynecologic oncologyYoung AdultEarly ovarian cancer; Laparoscopy; Ovarian cancer; Adolescent; Adult; Aged; Aged; 80 and over; Child; Female; Humans; Laparoscopy; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Retrospective Studies; Young AdultOvarian cancerLaparotomymedicine80 and overHumansEarly ovarian cancer; Laparoscopy; Ovarian cancer; Adolescent; Adult; Aged; Aged 80 and over; Child; Female; Humans; Laparoscopy; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Retrospective Studies; Young AdultStage (cooking)LaparoscopyChildAgedNeoplasm StagingRetrospective StudiesAged 80 and overOvarian Neoplasmsmedicine.diagnostic_testbusiness.industryOvarian cancer Early ovarian cancer LaparoscopyMedicine (all)Obstetrics and GynecologyRetrospective cohort studyPerioperativeMiddle Agedmedicine.diseasePrognosisSurgerySerous fluidSettore MED/40 - GINECOLOGIA E OSTETRICIAOncologyEarly ovarian cancerFemaleLaparoscopybusinessOvarian cancer
researchProduct

The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.

2014

STUDY QUESTION: Does the combined oral contraceptive pill (COCP) change endometrial gene expression when used for cycle programming? SUMMARY ANSWER: COCP used for scheduling purposes does not have a significant impact on endometrial gene expression related to endometrial receptivity. WHAT IS KNOWN ALREADY: Controversy exists around COCP pretreatment for IVF cycle programming as some authors claim that it might be detrimental to the live birth rate. Microarray technology applied to the study of tissue gene expression has previously revealed the behavior of genes related to endometrial receptivity under different conditions. STUDY DESIGN SIZE AND DURATION: Proof-of-concept study of 10 young h…

Adultmedicine.medical_specialtyAdolescentmedicine.medical_treatmentPopulationUterusGene ExpressionEndometriumEndometriumYoung AdultOvulation InductionmedicineHumansEmbryo ImplantationeducationMenstrual CycleGynecologyeducation.field_of_studyPregnancymedicine.diagnostic_testGenitourinary systembusiness.industryRehabilitationObstetrics and Gynecologymedicine.diseaseContraceptives Oral Combinedmedicine.anatomical_structureReproductive MedicineFemaleCombined oral contraceptive pillLive birthbusinessEndometrial biopsyHuman reproduction (Oxford, England)
researchProduct

Successful treatment of a young patient with locally advanced clear cell adenocarcinoma of the uterine cervix undergoing chemoradiation followed by r…

2014

Clear cell adenocarcinoma (CCAC) of the uterine cervix is a rare variant of cervical adenocarcinoma accounting for approximately 4-9% of this disease. Given the rarity of this pathological entity, the optimal treatment management is far from being defined. Earlier evidence suggested that the prognosis of patients bearing cervical CCAC is worse than with other histotypes, thus making the investigation of multimodal treatment strategies clinically worthwhile. Herein, we report the first case of locally advanced, large size cervical CCAC in a young woman who was triaged to concomitant chemoradiotherapy followed by radical surgery and experienced a pathologically assessed optimal response to th…

Adultmedicine.medical_specialtyAdvanced clear cell adenocarcinomaUterine Cervical NeoplasmRadical surgeryUterine Cervical NeoplasmsDisease-Free SurvivalObstetrics and gynaecologyadenocarcinoma uterine cervixUterine cervixmedicineHumansCombined Modality TherapyClear-cell adenocarcinomaRadical surgeryPathologicalSettore MED/08 - ANATOMIA PATOLOGICAbusiness.industryObstetrics and GynecologyMultimodal therapyChemoradiotherapy Adjuvantmedicine.diseaseMultimodal approachCombined Modality TherapyImmunohistochemistryMagnetic Resonance ImagingSurgeryChemoradiationReproductive MedicineAdenocarcinomaFemalebusinessChemoradiotherapyAdenocarcinoma Clear CellHuman
researchProduct

Neonatal outcome following long-distance air travel for fetoscopic laser coagulation treatment of twin-to-twin transfusion syndrome

2011

Abstract Objective To investigate the impact of undertaking long-distance air travel to a specialized medical center while pregnant in order to undergo fetoscopic laser coagulation (FLC) for twin-to-twin transfusion syndrome (TTTS). Methods A retrospective cohort study was conducted of women with TTTS who travelled by air (n = 16) or land (n = 61) to the Centre of Perinatal Diagnosis and Microinvasive Fetal Surgery, Mainz, Germany, between January 1, 2006, and December 31, 2010. All women underwent FLC on arrival at the study center. Neonatal outcome, postoperative neonatal survival rates, and rates of adverse effects were recorded. Results The postoperative survival rate for a single twin …

Adultmedicine.medical_specialtyAircraftmedicine.medical_treatmentTwin-to-twin transfusion syndromeFetoscopyMonochorionic twin pregnancyFetoscopic laser coagulationPregnancyGermanyMedicineHumansTertiary care medical centerAdverse effectSurvival rateRetrospective StudiesPregnancyAir PressureTravelLaser Coagulationmedicine.diagnostic_testbusiness.industryObstetricsFetal surgeryFetoscopyTwin-to-twin transfusion syndromeInfant NewbornObstetrics and GynecologyRetrospective cohort studyGeneral MedicineFetofetal Transfusionmedicine.diseaseSurvival RateTreatment OutcomePregnancy TwinFemalebusinessLaser coagulationAir travelInternational Journal of Gynecology & Obstetrics
researchProduct

Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer

2007

Patients with cervical cancer frequently suffer from anemia. This two-stage, adaptive-design study investigated the effect of anemia correction with epoetin beta on treatment outcomes. Patients with stage IIB–IVA cervical cancer received radiochemotherapy (RCT) and were randomized to epoetin 150 IU/kg three times weekly (n = 34) or standard care (control; n = 40) for up to 12 weeks. Primary end point for stage 1 aimed to establish a correlation between anemia correction and treatment failure (no complete response or relapsing within 6 months after RCT initiation) as a proof of concept before moving into stage 2. Secondary end points included progression/relapse-free survival, overall surviv…

Adultmedicine.medical_specialtyAnemiaInjections Subcutaneousmedicine.medical_treatmentUterine Cervical NeoplasmsRisk AssessmentGastroenterologyDrug Administration Schedulelaw.inventionRandomized controlled trialReference ValueslawInternal medicinemedicineClinical endpointHumansAdverse effectErythropoietinSurvival analysisNeoplasm StagingProbabilityCervical cancerChemotherapyEpoetin betaDose-Response Relationship Drugbusiness.industryObstetrics and GynecologyAnemiaMiddle Agedmedicine.diseaseCombined Modality TherapyImmunohistochemistrySurvival AnalysisRecombinant ProteinsSurgeryLogistic ModelsTreatment OutcomeOncologyChemotherapy AdjuvantFemaleRadiotherapy AdjuvantbusinessFollow-Up StudiesInternational Journal of Gynecologic Cancer
researchProduct

Maternal and Neonatal Characteristics for Late Foetal Death in Latvia between 2001 and 2014: Population-Based Study

2018

Introduction. Stillbirth is one of the most common adverse pregnancy outcomes worldwide. Late foetal death (LFD) rates are mostly used for international comparisons because of the large variations in stillbirth rates between countries. Objective. To examine trends in LFD (including antepartum and intrapartum) by multiple births, birth weight, and maternal age in two time periods. Methods. A retrospective cohort study was used to analyse data from the Medical Birth Register (2001–2014), divided into 2 periods of 7 years each. In total, data on 1,340 singletons were analysed. This study calculated LFD rates and rate ratios (RR). Results. The overall LFD rate showed a slight statistically sign…

Adultmedicine.medical_specialtyArticle SubjectBirth weightGestational Agelcsh:Gynecology and obstetricsYoung Adult03 medical and health sciences0302 clinical medicinePregnancyRisk FactorsmedicineFoetal deathBirth WeightHumansRegistries030212 general & internal medicineYoung adultlcsh:RG1-991reproductive and urinary physiologyRetrospective StudiesPregnancyChi-Square Distribution030219 obstetrics & reproductive medicineObstetricsbusiness.industryMortality rateInfant Newbornfood and beveragesObstetrics and GynecologyGestational agePrenatal CareRetrospective cohort studyStillbirthmedicine.diseaseLatviafemale genital diseases and pregnancy complicationsPopulation SurveillancePremature BirthFemalebusinessChi-squared distributionResearch ArticleJournal of Pregnancy
researchProduct

(Partial) loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes

2015

study hypothesis: Loss of protein BAF250a (ARID1A) expression is present in women with rectovaginal deep-infiltrating endometriosis (DIE) and endometriosis affecting the pelvic sentinel lymph nodes (PSLN). study finding: Partial loss of protein BAF250a was found in some of our patient samples, comprising all endometriosis entities, including rectovaginal DIE and endometriosis affecting the PSLN. what is known already: Loss of BAF250a (BRG-associated factor 250a)/ARIDIA (AT-rich interactive domain 1A) protein expression was identified among endometriosis-associated ovarian carcinomas and ovarian endometriosis, and this phenomenonwas described as a possible early event in the transformation o…

Adultmedicine.medical_specialtyBAF250a human proteinEmbryologyARID1APelvic sentinel lymph nodePopulationEndometriosisEndometriosisDeep-infiltrating endometriosiEndometriumGastroenterologyMalignant transformation03 medical and health sciencesEndometriumYoung Adult0302 clinical medicineGeneticInternal medicineGeneticsmedicinePTENHumanseducationMolecular BiologyCancerOvarian Neoplasmseducation.field_of_study030219 obstetrics & reproductive medicinebiologyCancerNuclear ProteinsObstetrics and GynecologyCell BiologyMiddle Agedmedicine.diseaseImmunohistochemistryARID1ADNA-Binding Proteinsmedicine.anatomical_structureReproductive Medicine030220 oncology & carcinogenesisOvarian Endometriosisbiology.proteinFemaleSentinel Lymph NodeTranscription FactorsDevelopmental Biology
researchProduct

Biliary sludge and gallstones in pregnancy: Incidence, risk factors, and natural history

1993

To evaluate the incidence and symptoms of and risk factors for biliary sludge and gallstones during pregnancy and to assess the natural history of these conditions in the first year after delivery.Cohort study.A total of 272 pregnant women recruited in the first trimester.Biliary sludge and gallstones were diagnosed using ultrasonography, both during pregnancy and after delivery. Predictors of the presence or disappearance of sludge and stones were examined.Overall, from the first trimester of pregnancy until the immediate postpartum period, 67 women were newly diagnosed with biliary sludge, and 6 women were newly diagnosed with gallstones. The respective incidence rates were 31% (95% Cl, 2…

Adultmedicine.medical_specialtyBiliary Tract DiseasesStatistics as TopicGastroenterologyCholelithiasisPregnancyRisk FactorsInternal medicineInternal MedicinemedicineHumansBiliary sludgeProspective StudiesRisk factorUltrasonographyPregnancyObstetricsbusiness.industryGallbladderIncidence (epidemiology)IncidencePostpartum PeriodObstetrics and GynecologyGeneral MedicineGallstonesmedicine.diseaseNatural historyPregnancy Complicationsmedicine.anatomical_structureItalyFemalebusinessPostpartum period
researchProduct

Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics anal…

2011

Elevated serum progesterone levels at the end of the follicular phase in controlled ovarian stimulation (COS) leads to a poorer ongoing pregnancy rate in IVF cycles due to reduced endometrial receptivity. The objective of this study was to use microarray technology to compare endometrial gene expression profiles at the window of implantation according to the levels of circulating progesterone.For this prospective cohort study, microarray data were obtained from endometrial biopsies from 12 young healthy oocyte donors undergoing COS with pituitary suppression by either gonadotrophin-releasing hormone (GnRH) agonists or antagonists, and recombinant FSH. On the day of recombinant chorionic gon…

Adultmedicine.medical_specialtyBiologyEndometriumAndrologyEndometriumImmune systemOvulation InductionPregnancyInternal medicineProgesterone receptorGene expressionFollicular phasemedicineHumansEmbryo ImplantationProspective StudiesCell adhesionGeneProgesteroneOligonucleotide Array Sequence Analysisbusiness.industryGene Expression ProfilingRehabilitationObstetrics and GynecologyGeneral MedicineGenomicsGene expression profilingPregnancy rateEndocrinologymedicine.anatomical_structureFollicular PhaseGene Expression RegulationReproductive MedicineFemaleEndometrial receptivitybusinessFunctional genomicsHuman Reproduction
researchProduct